Compare Organon Pharma Indonesia Tbk. (SCPI) vs Wira Global Solusi Tbk. (WGSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Wira Global Solusi Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Wira Global Solusi Tbk. trades at Rp136 (market cap 293.99B, 26.27M 24h volume). The key difference: Wira Global Solusi Tbk. is far larger — about 2.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WGSH | |
|---|---|---|
Market Cap | 104.4B | 293.99B |
Volume | — | 26.27M |
Lot | — | 262.7K |
Turnover | — | 3.62B |
Average Price | — | 137.74 |
Value | — | 3.62B |
Indicative Equilibrium Price | — | 136 |
Indicative Equilibrium Volume | — | 765 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Wira Global Solusi Tbk.
PT Wira Global Solusi Tbk (the Company) was established under name PT Gcloud Teknologi Informasi based on Deed No. 5 dated September 7, 2015 of Bhuana Nurinsani, S.H., notary in Bandung. Ikin Wirawan is the ultimate beneficial owner and controlling shareholder of the Company.
Read more on WGSH →
